DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▼ |
---|---|---|---|---|---|
C1384666 | hearing impairment | G6PC3 | 92579 | glucose-6-phosphatase catalytic subunit 3 | Q9BUM1 |
C0018817 | Atrial Septal Defects | G6PC3 | 92579 | glucose-6-phosphatase catalytic subunit 3 | Q9BUM1 |
C0016522 | Foramen Ovale, Patent | G6PC3 | 92579 | glucose-6-phosphatase catalytic subunit 3 | Q9BUM1 |
C0036341 | Schizophrenia | FUCA2 | 2519 | alpha-L-fucosidase 2 | Q9BTY2 |
C0002895 | Anemia, Sickle Cell | FUCA2 | 2519 | alpha-L-fucosidase 2 | Q9BTY2 |
C0013295 | Duodenal Ulcer | FUCA2 | 2519 | alpha-L-fucosidase 2 | Q9BTY2 |
C0026697 | Mucolipidoses | FUCA2 | 2519 | alpha-L-fucosidase 2 | Q9BTY2 |
C0004364 | Autoimmune Diseases | FUCA2 | 2519 | alpha-L-fucosidase 2 | Q9BTY2 |
C1306459 | Primary malignant neoplasm | PI4K2A | 55361 | phosphatidylinositol 4-kinase type 2 alpha | Q9BTU6 |
C0006826 | Malignant Neoplasms | PI4K2A | 55361 | phosphatidylinositol 4-kinase type 2 alpha | Q9BTU6 |
C0006142 | Malignant neoplasm of breast | PI4K2A | 55361 | phosphatidylinositol 4-kinase type 2 alpha | Q9BTU6 |
C0079504 | Hermanski-Pudlak Syndrome | PI4K2A | 55361 | phosphatidylinositol 4-kinase type 2 alpha | Q9BTU6 |
C0017636 | Glioblastoma | PI4K2A | 55361 | phosphatidylinositol 4-kinase type 2 alpha | Q9BTU6 |
C0016667 | Fragile X Syndrome | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C1956346 | Coronary Artery Disease | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0699893 | Skin carcinoma | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0678222 | Breast Carcinoma | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C1621958 | Glioblastoma Multiforme | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C4479410 | MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0013384 | Dyskinetic syndrome | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0699885 | Carcinoma of bladder | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0020619 | Hypogonadism | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0023234 | Legg-Calve-Perthes Disease | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0007222 | Cardiovascular Diseases | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0086543 | Cataract | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024